AstraZeneca’s Tagrisso gains EC approval for NSCLC treatment
The approval was based on the outcomes from the Phase III LAURA trial.
Therapy Area
Pfizer’s colorectal cancer combo therapy gains accelerated approval from FDA
FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation
Palleon and Shanghai Henlius Biotech link on autoimmune therapy
Astellas and Sangamo sign capsid deal for neurological diseases
MSD makes obesity play in up to $2bn deal for Hansoh’s GLP-1RA asset
Abera and Orexo partner for vaccine powder formulations
Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
